酶替代疗法
医学
儿科
发病年龄
疾病
中国大陆
等位基因
聚合酶链反应
内科学
遗传学
基因
中国
生物
政治学
法学
作者
Xi Chen,Tingliang Liu,Mei‐Rong Huang,Jinjin Wu,Junxue Zhu,Ying Guo,Xinyi Xu,Fen Li,Jian Wang,Lijun Fu
出处
期刊:Genetic Testing and Molecular Biomarkers
[Mary Ann Liebert, Inc.]
日期:2017-04-10
卷期号:21 (6): 391-396
被引量:17
标识
DOI:10.1089/gtmb.2016.0424
摘要
We sought to understand the clinical course and molecular defects of infantile-onset Pompe disease (IOPD) among mainland Chinese patients.Twenty-five Chinese patients with IOPD were enrolled and clinical data were retrospectively reviewed. The entire coding region of the GAA gene was amplified by polymerase chain reaction and analyzed by direct sequencing.The median age at symptom onset was 3.4 months (range: 1.0-7.1 months) and 4.9 months (range: 2.7-8.3 months) at diagnosis. Only one patient received enzyme replacement therapy (ERT) and this child survived beyond the age of 2 years. Of the 24 patients not receiving ERT, all, but one patient, died at a median age of 8.3 months (range: 4.0-12.2 months). Thirteen novel and two common GAA mutations were identified in this study. The allelic frequency of c.2662G > T (p.Glu888X) was 23.1% in northern Chinese patients and 4.2% in southern Chinese patients, whereas the allelic frequency of c.1935C > A (p.Asp645Glu) was 20.8% in southern and 3.8% in northern Chinese patients.We identified the most common mutations in southern and northern Chinese patients with IOPD.
科研通智能强力驱动
Strongly Powered by AbleSci AI